List of works - Francesc Mitjans

Alpha v integrin antagonists induce the disassembly of focal contacts in melanoma cells

scientific article published in July 2000

Alphavbeta5-integrins mediate early steps of metastasis formation.

scientific article published in May 2005

Amide-to-ester substitution allows fine-tuning of the cyclopeptide conformational ensemble.

scientific article published on April 2010

An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice.

scientific article published on August 1995

Anti-migratory and anti-angiogenic effect of p16: a novel localization at membrane ruffles and lamellipodia in endothelial cells

scientific article published in January 2004

Dual effects of β3 integrin subunit expression on human pancreatic cancer models

scientific article

Dual effects of β3 integrin subunit expression on human pancreatic cancer models

scientific article published on 31 May 2011

In vivo therapy of malignant melanoma by means of antagonists of alphav integrins

scientific article published on 01 September 2000

Leukocyte recruitment in colon cancer: role of cell adhesion molecules, nitric oxide, and transforming growth factor beta1.

scientific article

Micropattern of antibodies imaged by shear force microscopy: comparison between classical and jumping modes

scientific article published on 17 October 2013

RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways.

scientific article published in December 2001

S100A7: from mechanism to cancer therapy

scientific article published on 21 August 2017

S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer

scientific article

Site-Specific Antibody Drug Conjugates Using Streamlined Expressed Protein Ligation

scientific article published on 22 October 2018

Synthesis and biological evaluation of novel indolocarbazoles with anti-angiogenic activity.

scientific article

Tackling lipophilicity of peptide drugs: replacement of the backbone N-methyl group of cilengitide by N-oligoethylene glycol (N-OEG) chains

scientific article published on 17 December 2013

The backbone N-(4-azidobutyl) linker for the preparation of peptide chimera.

scientific article published on 22 August 2013

Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody

scientific article published on 4 September 2013

Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD Peptides

scientific article published on 18 July 2018

Use of siRNAs and Antisense Oligonucleotides Against Survivin RNA to Inhibit Steps Leading to Tumor Angiogenesis

scientific article published in April 2004

List of works by Francesc Mitjans

Alpha v integrin antagonists induce the disassembly of focal contacts in melanoma cells

Alphavbeta5-integrins mediate early steps of metastasis formation.

Amide-to-ester substitution allows fine-tuning of the cyclopeptide conformational ensemble.

An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice.

Anti-migratory and anti-angiogenic effect of p16: a novel localization at membrane ruffles and lamellipodia in endothelial cells

Dual effects of β3 integrin subunit expression on human pancreatic cancer models

Dual effects of β3 integrin subunit expression on human pancreatic cancer models

In vivo therapy of malignant melanoma by means of antagonists of alphav integrins

Leukocyte recruitment in colon cancer: role of cell adhesion molecules, nitric oxide, and transforming growth factor beta1.

Micropattern of antibodies imaged by shear force microscopy: comparison between classical and jumping modes

RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways.

S100A7: from mechanism to cancer therapy

S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer

Site-Specific Antibody Drug Conjugates Using Streamlined Expressed Protein Ligation

Synthesis and biological evaluation of novel indolocarbazoles with anti-angiogenic activity.

Tackling lipophilicity of peptide drugs: replacement of the backbone N-methyl group of cilengitide by N-oligoethylene glycol (N-OEG) chains

The backbone N-(4-azidobutyl) linker for the preparation of peptide chimera.

Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody

Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD Peptides

Use of siRNAs and Antisense Oligonucleotides Against Survivin RNA to Inhibit Steps Leading to Tumor Angiogenesis